Clinical Trial Update: Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on intravenous mesenchymal stem cell therapy for ischemia-reperfusion injury in patients with myocardial infarction, spanning Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• intravenous mesenchymal stem cell therapy

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Myocardial Infarction | Phase 1, Phase 2 | Status: UNKNOWN